Moderna Inc (MRNA)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 14,142,000 | 18,426,000 | 25,858,000 | 24,669,000 | 7,337,000 |
| Total stockholders’ equity | US$ in thousands | 10,901,000 | 13,854,000 | 19,123,000 | 14,145,000 | 2,561,000 |
| Financial leverage ratio | 1.30 | 1.33 | 1.35 | 1.74 | 2.86 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $14,142,000K ÷ $10,901,000K
= 1.30
The financial leverage ratio measures the extent to which a company relies on debt financing rather than equity. For Moderna Inc, the financial leverage ratio has shown a gradual decrease from 2.86 in 2020 to 1.30 in 2024. This indicates that the company has been reducing its reliance on debt over the years, moving towards a more balanced capital structure. A lower financial leverage ratio suggests decreased financial risk and potentially improved financial health. It seems that Moderna Inc has been managing its debt levels effectively, which could positively impact its overall financial stability and performance in the long run.
Peer comparison
Dec 31, 2024